West Pharmaceutical Services Profit Margin 2006-2019 | WST

Current and historical gross margin, operating margin and net profit margin for West Pharmaceutical Services (WST) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. West Pharmaceutical Services net profit margin as of March 31, 2019 is 12.53%.
West Pharmaceutical Services Annual Profit Margins
West Pharmaceutical Services Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $8.922B $1.717B
West Pharmaceutical Services, Inc. is a global drug delivery technology company that applies proprietary materials science, formulation research and manufacturing innovation to advance the quality, therapeutic value, development speed and rapid market availability of pharmaceuticals, biologics, vaccines and consumer healthcare products. West is the world's premiere provider of standard-setting systems and device components for parenterally administered medicines and an emerging leader in the development of advanced formulation technologies for the transmucosal delivery of drugs. West contract manufacturing harnesses a powerful combination of innovation, technology, infrastructure and expertise to serve the pharmaceutical, medical and consumer industries. Along with more than 50 years of experience, they bring customers quality, safety and reliability in injection molding, contract assembly and finished packaging.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $67.660B 22.54
McKesson (MCK) United States $25.888B 10.22
Align Technology (ALGN) United States $22.498B 60.74
AmerisourceBergen (ABC) United States $17.974B 12.76
Laboratory Of America Holdings (LH) United States $17.064B 15.95
Cooper (COO) United States $16.406B 28.36
Cardinal Health (CAH) United States $13.410B 8.69
DENTSPLY SIRONA (XRAY) United States $13.260B 27.64
Straumann Holding AG (SAUHF) Switzerland $13.158B 0.00
Henry Schein (HSIC) United States $10.063B 16.92
Merit Medical Systems (MMSI) United States $3.026B 31.44
CONMED (CNMD) United States $2.380B 37.97
Patterson (PDCO) United States $1.933B 14.49
Atrion (ATRI) United States $1.423B 40.63
STAAR Surgical (STAA) United States $1.381B 94.09
Antares Pharma (ATRS) United States $0.504B 0.00
Lifevantage (LFVN) United States $0.155B 20.49
Invacare (IVC) United States $0.151B 0.00
Endologix (ELGX) United States $0.116B 0.00
Pro-Dex (PDEX) United States $0.058B 17.87
Biolase (BIOL) United States $0.034B 0.00